ES2715005T3 - Extractos vegetales para mejorar la salud y la función cognitiva - Google Patents

Extractos vegetales para mejorar la salud y la función cognitiva Download PDF

Info

Publication number
ES2715005T3
ES2715005T3 ES13828399T ES13828399T ES2715005T3 ES 2715005 T3 ES2715005 T3 ES 2715005T3 ES 13828399 T ES13828399 T ES 13828399T ES 13828399 T ES13828399 T ES 13828399T ES 2715005 T3 ES2715005 T3 ES 2715005T3
Authority
ES
Spain
Prior art keywords
cognitive
memory
mice
acid
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13828399T
Other languages
English (en)
Spanish (es)
Inventor
Michael Ceddia
Kelli Herrlinger
Brandon Lewis
Harry Feng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kemin Industries Inc
Original Assignee
Kemin Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kemin Industries Inc filed Critical Kemin Industries Inc
Application granted granted Critical
Publication of ES2715005T3 publication Critical patent/ES2715005T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
ES13828399T 2012-08-09 2013-08-09 Extractos vegetales para mejorar la salud y la función cognitiva Active ES2715005T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261681414P 2012-08-09 2012-08-09
PCT/US2013/054274 WO2014026081A1 (en) 2012-08-09 2013-08-09 Plant extracts for improving cognitive health and function

Publications (1)

Publication Number Publication Date
ES2715005T3 true ES2715005T3 (es) 2019-05-31

Family

ID=50066333

Family Applications (1)

Application Number Title Priority Date Filing Date
ES13828399T Active ES2715005T3 (es) 2012-08-09 2013-08-09 Extractos vegetales para mejorar la salud y la función cognitiva

Country Status (11)

Country Link
US (2) US20140044813A1 (https=)
EP (1) EP2882443B1 (https=)
JP (4) JP2015524484A (https=)
KR (1) KR101947352B1 (https=)
CN (2) CN104684562A (https=)
AU (1) AU2013299491B2 (https=)
BR (1) BR112015002739A2 (https=)
CA (1) CA2880708C (https=)
ES (1) ES2715005T3 (https=)
PL (1) PL2882443T3 (https=)
WO (1) WO2014026081A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140044813A1 (en) * 2012-08-09 2014-02-13 Kemin Industries, Inc. Plant Extracts for Improving Cognitive Health and Function
JP2017507125A (ja) * 2014-01-30 2017-03-16 ケミン、インダストリーズ、インコーポレーテッドＫｅｍｉｎ Ｉｎｄｕｓｔｒｉｅｓ， Ｉｎｃ． 認知機能を向上させるための植物抽出物
JP2017527591A (ja) * 2014-09-15 2017-09-21 ケミン、インダストリーズ、インコーポレーテッドＫｅｍｉｎ Ｉｎｄｕｓｔｒｉｅｓ， Ｉｎｃ． 認知機能向上のための植物抽出物
MX2017004582A (es) * 2014-10-08 2017-10-12 Abbott Lab Composiciones nutricionales que comprenden un componente oxidable y un extracto de plantas solubles en agua.
EP3538085B1 (en) * 2016-11-11 2023-07-12 Kemin Industries, Inc. Use of a spearmint extract for improving the rate of neurogenesis
CN106727915B (zh) * 2017-01-18 2020-03-31 云南德彩堂生物医药科技有限公司 一种稳定高效提高记忆的组合物及其制备方法和应用
EP3703675A4 (en) * 2017-10-30 2021-06-16 Neuropore Therapies, Inc. SUBSTITUTED PHENYLSULFONYLPHÉNYLTRIAZOLETHIONES AND ASSOCIATED USES
CN109602759B (zh) * 2019-01-17 2020-10-09 广西医科大学 罗汉松实多糖的用途
KR102421772B1 (ko) * 2019-05-21 2022-07-18 건국대학교 글로컬산학협력단 클로로필 및 로즈마린산을 포함하는 미세먼지에 의해 유발된 신경염증 또는 신경 퇴행성 질환의 예방 또는 치료용 조성물
CN110463846A (zh) * 2019-07-30 2019-11-19 河南科技学院 留兰香提取物在制备抗宠物衰老药物或宠物食品中的应用
JP7330630B2 (ja) * 2019-11-20 2023-08-22 株式会社ニップン ロスマリン酸及びカルノシン酸を有効成分とする神経突起伸長誘導作用を有する組成物
JP2022104122A (ja) * 2020-12-28 2022-07-08 株式会社ニップン オキシトシン関連シグナル活性化剤
JP2026503187A (ja) * 2022-10-27 2026-01-28 ケミン、インダストリーズ、インコーポレーテッド 網膜神経栄養のためのスペアミント抽出物の使用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999059606A1 (en) * 1998-05-16 1999-11-25 Mogam Biotechnology Research Institute Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process
JP4629822B2 (ja) * 1999-12-02 2011-02-09 長瀬産業株式会社 神経成長因子合成促進剤
JP2006199666A (ja) * 2005-01-24 2006-08-03 Nagase & Co Ltd 健忘症の予防・治療剤
EP1940389A2 (en) * 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP1930019A1 (en) * 2006-11-24 2008-06-11 DSMIP Assets B.V. Rosemary extracts, dietary and pharmaceutical compositions containing them and their uses
EP1925213A1 (en) * 2006-11-24 2008-05-28 DSMIP Assets B.V. Dietary and pharmaceutical compositions comprising a sage extract comprising a mixture of tricyclic diterpenes and their derivatives and their uses
US20100137433A1 (en) * 2007-01-24 2010-06-03 Laima Kott Production of Rosmarinic Acid from Spearmint and uses Thereof
US7972633B2 (en) * 2007-02-07 2011-07-05 Applied Cognitive Sciences, LLC Nutritional supplements for healthy memory and mental function
ES2561330T3 (es) * 2007-10-17 2016-02-25 Rudolf Wild Gmbh & Co. Kg Composición que comprende extractos de toronjil
AU2010258356B2 (en) * 2009-06-12 2017-01-19 Generex Pharmaceuticals, Inc. Compositions and methods for prevention and treatment of brain diseases and conditions
CN101773488A (zh) * 2010-02-10 2010-07-14 青岛大学 一种基于迷迭香酸的药物及其在治疗帕金森病中的应用
JP2011256118A (ja) * 2010-06-07 2011-12-22 Kao Corp Ｉｌ−８及びｇｍ−ｃｓｆ発現抑制剤
US20140044813A1 (en) * 2012-08-09 2014-02-13 Kemin Industries, Inc. Plant Extracts for Improving Cognitive Health and Function

Also Published As

Publication number Publication date
WO2014026081A1 (en) 2014-02-13
KR101947352B1 (ko) 2019-02-12
CA2880708C (en) 2023-09-26
CA2880708A1 (en) 2014-02-13
KR20150041654A (ko) 2015-04-16
EP2882443B1 (en) 2019-01-16
AU2013299491B2 (en) 2018-03-15
US20250009703A1 (en) 2025-01-09
US20140044813A1 (en) 2014-02-13
EP2882443A4 (en) 2016-01-06
JP2023027232A (ja) 2023-03-01
JP2015524484A (ja) 2015-08-24
JP2021066735A (ja) 2021-04-30
AU2013299491A1 (en) 2015-02-12
JP2025029029A (ja) 2025-03-05
BR112015002739A2 (pt) 2017-07-04
CN104684562A (zh) 2015-06-03
PL2882443T3 (pl) 2019-06-28
EP2882443A1 (en) 2015-06-17
CN111358832A (zh) 2020-07-03

Similar Documents

Publication Publication Date Title
ES2715005T3 (es) Extractos vegetales para mejorar la salud y la función cognitiva
Chaudhari et al. Neurocognitive effect of nootropic drug Brahmi (Bacopa monnieri) in Alzheimer's disease
Sharman et al. Assessment of diets containing curcumin, epigallocatechin-3-gallate, docosahexaenoic acid and α-lipoic acid on amyloid load and inflammation in a male transgenic mouse model of Alzheimer's disease: Are combinations more effective?
Abu-Taweel et al. Pomegranate juice reverses AlCl3-Induced neurotoxicity and improves learning and memory in female mice
Patel et al. Neuroprotective effect of lutein in scopolamine-induced Alzheimer’s disease in mice and zebrafish
Schaffer et al. Plant foods and brain aging: a critical appraisal
Moradi Vastegani et al. Anethole attenuates motor dysfunctions, striatal neuronal activity deficiency and blood brain barrier permeability by decreasing striatal α-synuclein and oxidative stress in rotenone-induced Parkinson’s disease of male rats
Bao et al. Egg yolk phospholipids reverse scopolamine–induced spatial memory deficits in mice by attenuating cholinergic damage
Cho et al. Neuroprotective effects of Actinidia eriantha cv. Bidan kiwifruit on amyloid beta-induced neuronal damages in PC-12 cells and ICR mice
Shukla et al. Learning and memory enhancing activity of polyherbal formulation on streptozotocin induced memory impairment in rats via reducing mitochondria–targeted cytochrome
CA2838976C (en) Dha and epa in the reduction of oxidative stress
EP3461479A1 (en) Nutraceutical and pharmaceutical compositions, and uses thereof for preserving cognitive functions
AU2021204964A1 (en) Composition for use in the treatment of cognitive disorders
Marcos et al. Cognition and Omega-3 Fatty Acids-A Narrative Review of the Literature
Supriadi et al. Centella asiatica protect the development of aluminum-induced zebrafish larvae
Ghibhela et al. Chapter-3 Brahmi: A Memory Booster Medicinal Herb
Navarro Hortal Evaluation of redox-based bioactive compounds obtained from products and by-products of agri-food industry and beekeeping of interest in aging and aging-related diseases
Reddy Neuroprotective effects of Abelmoschus moschatus seed extract on fluoride-induced myelin degeneration in developing brain of rats
IT201800007640A1 (it) Composizione per prevenire o trattare forme di declino cognitivo
Puicǎ et al. PROTECTIVE EFFECTS OF A BIOACTIVE ANTIOXIDANT COMPLEX AGAINST ASPARTAME EXPOSURE DURING GESTATION. BIOCHEMICAL, MORPHOLOGICAL AND ULTRASTRUCTURAL STUDIES ON NEW-BORN RAT BRAIN.
Marques Role of nutrition in adult neurogenesis
Calvi HIGH-FAT DIET-INDUCED BRAIN DAMAGES: NEW NUTRACEUTICAL APPROACHES
Sharma TOXICITY INDUCED BY CONCURRENT EXPOSURE OF DIMETHOATE AND FLUORIDE AND ITS AMELIORATION BY ZINGIBER OFFICINALE
ES3055280A1 (es) Extracto de Ulva australis con actividad antioxidante y actividad proliferativa celular
Ghrita impairment and oxidative stress in pentylenetetrazole induced seizures in rats